Faster Australian Medicine Approvals through Leveraging International Evaluations 20 May 2020
The Australian Therapeutic Goods Administration recently implemented several new initiatives that enable sponsors to utilise regulatory approvals from other jurisdictions (e.g. USA, Canada, Europe) to accelerate prescription medicine approval in Australia. This webinar outlines how these processes work, what criteria are applied, and the corresponding impact on regulatory timelines – a must-listen for those seeking Australian approvals for Prescription Medicines, Biological Medicines, Generics and Biosimilars in this presentation.
Presenter: Robert Stringer, Director and Principal Consultant, Brandwood CKC